Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04118998 · ClinicalTrials.gov registry record · NA

Progressive Abduction Loading Therapy

A NA study of Stroke, Acute, sponsored by Northwestern University.

Active
Registry status
NA
Development phase
86
Enrollment target
3
Study locations

NCT04118998 is a NA study of Stroke, Acute that is active but no longer recruiting, run by Northwestern University. The registered enrollment target is 86 participants, below the 627-participant average among 25 other Stroke, Acute trials with a reported enrollment target (86% lower). The trial reports 3 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04118998, a NA study of Stroke, Acute, is active but no longer recruiting, sponsored by Northwestern University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
86 participants
Enrollment target
3
Study locations

Study Summary

This study attempts to minimize the development of a common movement impairment following stroke known as "flexion synergy" that makes it extremely difficult to reach outward with the arm. Participants with acute/subacute stroke will receive one of two study interventions in addition to prescribed therapies in both inpatient rehabilitation and day-rehab. Participants will be followed for 1 year.

Conditions Studied

Interventions

  • BEHAVIORAL Abduction Loading
  • BEHAVIORAL Supported Reaching

Study Locations (3)

Illinois

  • Department of Physical Therapy and Human Movement Sciences - Chicago
  • Shirley Ryan AbilityLab - Chicago
  • Northwestern Medicine Marianjoy Rehabilitation Hospital - Wheaton

Trial Details

FieldValue
Enrollment Target 86 participants
Start Date 2021-08-27
Est. Completion 2026-08-31
Phase NA

Sponsor

Northwestern University

1,209 total trials

What the Registry Record Tells You About NCT04118998

The ClinicalTrials.gov registry entry for NCT04118998 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 86 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 627-participant average among 25 other Stroke, Acute trials with a reported enrollment target (86% lower). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Stroke, Acute appearing as the primary indexed condition, and to 2 interventions - of which Abduction Loading is the first listed.

NCT04118998 reports 3 study locations spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT04118998 about?

NCT04118998 is a clinical study titled "Progressive Abduction Loading Therapy". This study attempts to minimize the development of a common movement impairment following stroke known as "flexion synergy" that makes it extremely difficult to reach outward with the arm. Participants with acute/subacute stroke will receive one of two study interventions in addition to prescribed t...

What is the current status of trial NCT04118998?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 86 participants. The study started on 2021-08-27. Estimated completion is 2026-08-31.

What conditions does trial NCT04118998 study?

This clinical trial studies the following conditions: Stroke, Acute.

What interventions are being tested in trial NCT04118998?

The interventions under investigation include: Abduction Loading (BEHAVIORAL), Supported Reaching (BEHAVIORAL).

Who is sponsoring clinical trial NCT04118998?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04118998 being conducted?

This trial has 3 study locations across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke, Acute

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.